111

MAXIGEN BIOTECH INC

No trades
See on Supercharts

1783 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Maxigen Biotech, Inc. engages in the business of collagen purification; research and development, production, and selling implantable medical device; and producing, manufacturing, wholesaling, and retailing cosmetics. It operates through the following segments: Biomedical Products, Consumer Products, and Others. The Biomedical Products segment includes manufacturing and selling collagen and bone materials. The Consumer Products segment focuses on beauty care products. The company was founded on December 3, 1998 and is headquartered in Taoyuan, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

1783 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company